Related Experiment Video
Updated: Jan 23, 2026

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
Atheroma and systemic lupus erythematosus
Martin Soubrier1, Sylvain Mathieu, Jean-Jacques Dubost
1G. Montpied Hospital, Service de Rhumatologie, Place Henri Dunant, BP 69, 63003 Clermont-Ferrand, France. msoubrier@chu-clermontferrand.fr
Insights
Patients with systemic lupus erythematosus (SLE) face significantly higher cardiovascular risk, driven by inflammation and conventional factors. Managing SLE and its risk factors is crucial for reducing heart disease in these individuals.
Area of Science:
- Rheumatology
- Cardiology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is associated with a marked increase in cardiovascular risk.
- Subclinical atherosclerosis, including increased intima-media thickness and plaque formation, is prevalent in SLE patients.
- Traditional cardiovascular risk factors do not fully account for the elevated risk observed in SLE.
Purpose of the Study:
- To review the epidemiology and contributing factors of cardiovascular disease (CVD) in patients with SLE.
- To highlight the role of inflammation and immunological disturbances in SLE-related CVD.
- To discuss management strategies for cardiovascular risk in SLE.
Main Methods:
- Review of epidemiologic data and non-invasive cardiovascular investigations in SLE patients.
- Analysis of the interplay between SLE, conventional risk factors, and CVD.
- Discussion of potential therapeutic interventions and risk factor management.
Main Results:
- SLE patients exhibit increased markers of subclinical atherosclerosis compared to controls.
- Inflammation and immunological factors likely contribute to CVD risk through dyslipidemia and insulin resistance.
- The role of glucocorticoids in SLE-associated CVD remains debated.
Conclusions:
- Effective SLE disease control is expected to lower cardiovascular morbidity and mortality.
- Optimal management of conventional risk factors like obesity, smoking, and physical inactivity is essential.
- Aggressive treatment of hypertension and dyslipidemia, alongside assessment of antiplatelet therapy, is recommended for SLE patients.
Abstract:
Epidemiologic data indicate a large increase in cardiovascular risk in patients with systemic lupus erythematosus (SLE). Non-invasive investigations show increases in intima-media thickness, carotid plaque, and coronary artery calcifications in patients with SLE, compared to controls. Conventional cardiovascular risk factors may fail to fully explain the high cardiovascular risk in SLE patients. Immunological disturbances and inflammation may indirectly contribute to the risk of cardiovascular disease by inducing dyslipidemia and/or insulin resistance. The potential role for glucocorticoid therapy is controversial. Effective control of the disease would be expected to decrease the cardiovascular morbidity and mortality rates. Careful attention should be given to controlling conventional risk factors such as obesity, smoking, and physical inactivity. Hypertension and/or dyslipidemia should be treated optimally. The appropriateness of antiplatelet therapy should be assessed.
Related Concept Videos
Second Order systems II
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
Second Order systems I
By reinterpreting the system, one can derive the closed-loop transfer function, which...
Classification of Systems-I
Homogeneity dictates that if an input x(t) is multiplied by a constant c, the output y(t) is multiplied by the same constant. Mathematically, this is expressed as:
Classification of Systems-II
Mechanical Systems

